Status:
WITHDRAWN
Perception of Cure Among Patients With Metastatic Cancer
Lead Sponsor:
City of Hope Medical Center
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Hematopoietic and Lymphoid Cell Neoplasm
Metastatic Malignant Solid Neoplasm
Eligibility:
All Genders
18+ years
Brief Summary
This study collects information about perception of cure among patients with cancer that has spread to other places in the body (metastatic). This study aims to determine patients' perception (knowled...
Detailed Description
PRIMARY OBJECTIVE: I. To assess the proportion of patients with metastatic cancer who anticipate cure before starting immunotherapy. SECONDARY OBJECTIVES: I. To determine if expectations of cure ar...
Eligibility Criteria
Inclusion
- Eligibility Criteria:
- Patients must be aged 18 and over
- Patients sufficiently fluent in English
- Patients must have a cytologically or pathologically verified diagnosis of cancer
- Patients must have measurable metastatic disease
- Patients must be initiating immunotherapy
- Patients must be undergoing evaluation and treatment at City of Hope Cancer Center
Exclusion
Key Trial Info
Start Date :
October 30 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 5 2022
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04820894
Start Date
October 30 2021
End Date
January 5 2022
Last Update
May 23 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.